pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Sep 1·1 min read
save

Trial over Lindsay Clancy’s case threatens progress in postpartum psychiatry

Sep 1, 2026·read at STAT ↗Negative

Opinion piece by reproductive psychiatrist Jennifer Okwerekwu notes that the ongoing Lindsay Clancy trial, in which a jury remains deadlocked after five weeks, pits a defense claim of health-care system failure against a prosecution argument of premeditation. The judge has asked jurors to keep deliberating.

Okwerekwu warns that the case is harming the field of reproductive psychiatry, fearing it will discourage treatment for postpartum mental illness and hurt patients who need help.

She clarifies she had no involvement in Clancy’s care and does not comment on guilt, but stresses the trial’s fallout could set back progress in addressing postpartum mental health.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: I’m a reproductive psychiatrist. The Lindsay Clancy trial will cause terrible damage to my field”

read at STAT ↗
2,993 words · retrieved Sep 1
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
CYCLE
topics
Psychiatry & CNS19Major Depression4Drug Shortage

related stories

  • Sep 21Behind the outcomes: How whole-patient support is reshaping oncology careBioPharma Dive
  • Sep 17Opinion: What happened to oppositional defiant disorder?STAT
  • Sep 5Opinion: What STAT readers think about M.D. vs. D.O., AI in medicine, surrogacy, and moreSTAT
  • Aug 24Nurse practitioner trainees find themselves stymied by shortage of clinical mentorsSTAT
  • Jul 28After PCOS became PMOS, there’s hope for new awareness among Black and Latina womenSTAT